… ) of Alzheimer's disease polygenic risk scores for increasing SNP inclusion P-value thresholds,
comparing Alzheimer's disease … of Alzheimer's disease subtypes in Alzheimer's disease …

… to study AD disease mechanisms. Here, we review the CSF proteomics literature to identify
… on these proteins to study which biological processes may be involved in the disease. …

… By comparing the cerebrospinal fluid (CSF) proteome between Alzheimer's disease (AD)
patients and controls, it may be possible to identify proteins that play a role in the disease …

… To find a panel of proteins in antemortem cerebrospinal fluid (CSF) that could be used to
differentiate between samples from Alzheimer's disease (AD) patients and samples from …

… Alzheimer's disease (AD) patients have higher CSF levels of … spectrometry (MS)-based
proteomics workflow for the in-depth … CSF proteome changes in Alzheimer's disease prove to be …

… Here, we used integrative proteomics to identify cerebrospinal fluid (CSF) biomarkers …
proteome resolved 44 biologically diverse modules, 15 of which overlapped with the CSF proteome…

… evolve over the course of the disease is currently unknown. Here we show that proteomic
measurements in autosomal dominant AD cerebrospinal fluid (CSF) linked to brain protein …

… detection, they are not suitable for monitor of disease … fluid proteome of Alzheimer’s disease
patients and non-demented controls to identify potential biomarkers for Alzheimer’s disease. …

… Here we define AD molecular subtypes using mass spectrometry proteomics in cerebrospinal
fluid, based on 1,058 proteins, with different levels in individuals with AD (n = 419) …

… cellular proteome that could provide insight into disease etiology … to how and whether
proteomics studies have contributed to … , several candidate cerebrospinal fluid biomarkers are now …